• No products in the list

p.D816V OncoKit

Short description

Decoding SM with p.D816V OncoKit

Focused on the challenges of Systemic Mastocytosis, a rare hematological condition, the p.D816V OncoKit offers unparalleled accuracy and precision in detecting the critical p.D816V mutation.

With its rigorous validation, high sensitivity, and compatibility with advanced lab setups, this research tool is a game-changer for healthcare and molecular biology professionals.

Product highlights

  • Digital PCR
  • Detection and quantification
  • Two-Target Multiplex Assay
  • Specialized for SM

Ask for a quote

p.D816V OncoKit



Instructions for Use

MSDS p.D816V OncoKit


For any missing information or if you require additional details, please do not hesitate to contact us. 

Specifications of the p.D816V OncoKit

The OncoKit Revolution: Pinpointing p.D816V in Systemic Mastocytosis

The p.D816V OncoKit is a transformative tool, designed to provide critical insights into the challenging landscape of Systemic Mastocytosis (SM), a rare hematological disorder. Utilizing advanced digital PCR (dPCR) technology, the kit offers an invaluable resource for healthcare technicians and molecular biology professionals.

Systemic Mastocytosis is a condition characterized by the abnormal proliferation and accumulation of mast cells in various tissues, including the skin, bone marrow, and other extracutaneous tissues. The disorder can manifest in a range of subtypes. It’s crucial to note that a staggering 90% or more of SM patients exhibit the p.D816V mutation, which has significant implications for both diagnosis and treatment strategies.

The KIT gene plays a pivotal role in encoding a protein essential for cellular proliferation. The p.D816V mutation presents a unique challenge as it disrupts the natural cellular equilibrium. This alteration leads to ligand-independent activation, causing an escalation in cellular proliferation while diminishing apoptosis rates. Importantly, this specific mutation shows resistance to certain tyrosine kinase inhibitors, underlining the critical need for its accurate detection to inform therapeutic decisions.

Why Opt for the p.D816V OncoKit

Unmatched Precision and Accuracy: Employs cutting-edge digital PCR technology for precise and accurate quantification of mutated and wild-type alleles.

User-Friendly Design: The kit has been thoughtfully designed to include all essential components, ensuring a hassle-free and efficient workflow for users.

Solid Validation Credentials: Backed by rigorous validation against synthetic DNA that includes both mutated and wild-type alleles, guaranteeing both reliability and consistency.

Exceptional Sensitivity: Features outstanding limits for both detection and quantification, thereby enabling the discovery of low-frequency mutation occurrences.

Broad Compatibility: Fully optimized for compatibility with leading PCR systems like QuantStudio™ Absolute Q™, offering a smooth transition into your existing lab infrastructure.

Elevate Your Research: Why OncoKit is the Go-To Resource

Navigating the complexities of hematological disorders like Systemic Mastocytosis requires robust, reliable, and precise tools that can adapt to the evolving landscape of medical research. The p.D816V OncoKit is precisely engineered to meet these needs. Offering a suite of exceptional features such as digital PCR technology, precise p.D816V mutation quantification, and seamless compatibility with advanced lab systems, the OncoKit sets a new standard in the field. For healthcare and molecular biology professionals committed to advancing their research in this critical area, the p.D816V OncoKit serves as an invaluable, rigorously validated resource that stands as a dependable cornerstone in any advanced laboratory setting.

Components of the p.D816V OncoKit

The kit is equipped with reagents for 24 reactions, including:

  • Master Mix cKIT dPCR OncoKit: specific oligonucleotides, FAMTM and VICTM TaqMan probes, and
    nuclease-free water to detect D816V of KIT gen by digital PCR.
  • Positive Control: mixture of synthetic DNA with the wild-type and mutated allele as
    heterozygous positive control.

Explore Related Items